The CEO of a Pharmaceutical Company Asked His Consultant If

Multiple Choice

The CEO of a pharmaceutical company asked his consultant if it was a good idea to implement the s-curve model to predict when a technology would reach its limits.The consultant identified a limitation in the use of the model.Which of the following is most likely the limitation identified by the consultant?

A) Firms cannot influence the shape of the s-curve through their developmental activities.
B) Unexpected changes in the market can alter the shape of a technology's s-curve.
C) S-curve models cannot be applied in the pharmaceutical industry.
D) S-curve models are outdated and unrealistic.